从毒损肺络论治吸烟引起的小气道阻塞
Discussion on treating small airway obstruction caused by smoking from the perspective of injury to pulmonary vessels
- 现代中医临床 2022年29卷第3期 页码：43-48
- 作者机构：
1.北京中医药大学 北京 100029
2.北京中医药大学东方医院
- 作者简介：
赵艳芬，女，在读硕士生
# 张永生，男，博士，主任医师，教授、硕士生导师，E-mail：zhyshengcm@163.com
- 基金信息：国家中医药管理局第五批全国中医优秀人才研修项目(国中医药办人教函[2022]1号)
DOI：10.3969/j.issn.2095-6606.2022.03.010
中图分类号： R259纸质出版日期：2022-05-30，
收稿日期：2021-05-16，
- 稿件说明：
移动端阅览
赵艳芬, 王琦, 姜云宁, 等. 从毒损肺络论治吸烟引起的小气道阻塞[J]. 现代中医临床, 2022,29(3):43-48.
Yanfen ZHAO, Qi WANG, Yunning JIANG, et al. Discussion on treating small airway obstruction caused by smoking from the perspective of injury to pulmonary vessels[J]. Modern Chinese Clinical Medicine, 2022,29(3):43-48.
赵艳芬, 王琦, 姜云宁, 等. 从毒损肺络论治吸烟引起的小气道阻塞[J]. 现代中医临床, 2022,29(3):43-48. DOI： 10.3969/j.issn.2095-6606.2022.03.010.
Yanfen ZHAO, Qi WANG, Yunning JIANG, et al. Discussion on treating small airway obstruction caused by smoking from the perspective of injury to pulmonary vessels[J]. Modern Chinese Clinical Medicine, 2022,29(3):43-48. DOI： 10.3969/j.issn.2095-6606.2022.03.010.
摘要
小气道隶属于肺络系统中的气络部分，小气道结构功能的病变影响整个肺络系统以及肺生理功能的正常发挥。小气道阻塞是慢性阻塞性肺疾病的早期阶段，吸烟是其主要的危险因素之一。结合“毒”邪理论和络病学说，认为烟草烟雾是本病的使动因素，烟雾对小气道的影响包括介导气道炎症反应、黏液分泌和气道阻塞以及肺内组织损伤。烟毒伤络过程包括：留滞气络积蕴成毒阶段、成毒络损阶段和络损内生新毒阶段。治疗强调排毒通络、益气养阴，初期留滞气络积蕴成毒阶段宜清肺润络排毒，烟雾积聚成毒络损阶段宜益气通络排毒，络损内生新毒阶段宜逐瘀化痰通络。
Abstract
Small airways belong to the qi collateral of the lung collaterals
and their damages may result in abnormalities of the entire lung collateral system
and its physiological functions. Small airways obstruction is the early stage of chronic obstructive pulmonary disease (COPD)
for which smoking has been recognized as one of the main risk factors. Based on a combination of the theory of "toxic" pathogen and of pulmonary collateral diseases
this study proposes that tobacco smoke is the driving factor of this disease. The injury of lung collaterals by tobacco smoke is manifested in its effect on small airways
which mediates airway inflammation
mucus secretion and eventual obstruction of the passages. Tissue damage in the lungs are caused by smoke invading qi collaterals
which mainly involves the stages smoke evil accumulating in the qi collaterals until toxic levels
the smoke toxins inducing collateral damage
and new toxins result ing from the damaged collaterals. For the treatment
the focus should be placed on removing the toxins and unblocking the collaterals
tonifying qi and nourishing yin. At the initial stage
it is advisable to clear the lungs
moisten collaterals and expel the toxins. At the second stage
the key is to nourish qi and unblock the collaterals and remove the toxins. To deal with the new toxins generated in the third stage
it is suggested to remove stasis
dissolve phlegm and unblock the collaterals.
关键词
慢性阻塞性肺疾病小气道阻塞吸烟毒损肺络毒邪理论络病学说
Keywords
chronic obstructive pulmonary diseasesmall airway obstructionsmokingtoxic damage to lungsthe theory of "toxin"the theory of collateral disease
references
Global Initiative For Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease 2021 report[EB/OL].(2020-11-17)[2021-02-06]. https://goldcopd.org/gold-reports/https://goldcopd.org/gold-reports/.
LOZANO R, NAGHAVI M, FOREMAN K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010[J].Lancet，2012, 380(9859):2095-2128.
WANG C, XU J, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health [CPH] study): a national cross-sectional study[J].Lancet，2018, 391(10131):1706-1717.
TANABE N，VASILESCU D M，KIRBY M，et al. Analysis of airway pathology in COPD using a combination of computed tomography，micro-computed tomography and histology[J/OL].Eur Respir J，2018，51：1701245[2021-02-06].https://doi.org/10.1183/13993003.01245-2017https://doi.org/10.1183/13993003.01245-2017.
MCDONOUGH J E, YUAN R, SUZUKI M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease[J].N Engl J Med，2011, 365(17):1567-1575.
HOGG J C, CHU F S, TAN W C, et al. Survival after lung volume reduction in chronic obstructive pulmonary disease：insights from small airway pathology[J].Am J Respir Crit Care Med，2007, 176(5):454-459.
XIAO D, CHEN Z, WU S, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study[J].Lancet Respir Med，2020, 8(11):1081-1093.
FAZLEEN A，WILKINSON T. Early COPD：current evidence for diagnosis and management[J/OL].Ther Adv Respir Dis，2020，14：1022290128[2021-02-06].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394029/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394029/.
KAWAMOTO T，KANAZAWA H，TOCHINO Y，et al. Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease[J/OL].Respir Med，2018，141：159-164[2021-02-06].https://pubmed.ncbi.nlm.nih.gov/30053962/https://pubmed.ncbi.nlm.nih.gov/30053962/.
HOGG J C, HACKETT T L. Structure and function relationships in diseases of the small airways[J].Ann Am Thorac Soc，2018, 15(Suppl 1):S18-S25.
MACKLEM P T. The physiology of small airways[J].Am J Respir Crit Care Med，1998, 157(5 Pt 2):S181-S183.
BARALDO S, TURATO G, SAETTA M. Pathophysiology of the small airways in chronic obstructive pulmonary disease[J].Respiration，2012, 84(2):89-97.
张英英，徐萌，刘金艳，等.试论“脏络”[J].中医杂志，2013, 54(21):1801-1804.
刘勇明，吕晓东，庞立健，等.基于肺络构效理论的肺脏生理功能发微[J].中华中医药学刊，2017, 35(10):2518-2520.
姜良铎，张文生.从毒论治初探[J].北京中医药大学学报，1998, 21(5):2-3.
姜良铎，秦英，杨君，等.试论“环境毒”[J].中国中医基础医学杂志，1999, 5(9):4-6.
张介宾. 景岳全书[M].北京：中国中医药出版社，1994:638-639.
倪朱谟. 本草汇言[M].上海：上海科技出版社，2005:329.
兰茂. 滇南本草：第3卷[M].昆明：云南科技出版社，2010:426.
赵学敏. 本草纲目拾遗[M].北京：中国中医药出版社，1998:23-26.
张安玲，丁元庆. 吸烟的病因属性及致病机制探讨[J].山东中医药大学学报，2013, 37(1):16-18.
徐治波，冯玉麟. 烟草工业与人类健康[M].成都：四川大学出版社，2013:68.
STRULOVICI-BAREL Y, OMBERG L, O'MAHONY M, et al. Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke[J].Am J Respir Crit Care Med，2010, 182(12):124-1532.
BI X, VITALI C, CUCHEL M. ABCA1 and Inflammation: from animal models to humans[J]. Arterioscler Thromb Vasc Biol，2015, 35(7):1551-1553.
FRANCONE O L, ROYER L, BOUCHER G, et al. Increased cholesterol deposition, expression of scavenger receptors，and response to chemotactic factors in Abca1-deficient macrophages[J].Arterioscler Thromb Vasc Biol，2005, 25(6):1198-1205.
KOTLYAROV S，KOTLYAROVA A. Bioinformatic analysis of ABCA1 gene expression in smoking and chronic obstructive pulmonary disease[J/OL]. Membranes，2021，11(9)：674[2022-02-05].https://www.mdpi.com/2077-0375/11/9/674https://www.mdpi.com/2077-0375/11/9/674.
TAKIZAWA H, TANAKA M, TAKAMI K, et al. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers[J]. Am J Physiol Lung Cell Mol Physiol，2000, 278(5):L906-L913.
INNES A L, WOODRUFF P G, FERRANDO R E, et al. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction[J]. Chest，2006, 130(4):1102-1108.
POLOSUKHIN V V, GUTOR S S, Du RH, et al. Small airway determinants of airflow limitation in chronic obstructive pulmonary disease[J]. Thorax，2021, 76(11):1079-1088.
WICKENDEN J A, CLARKE M C, ROSSI A G, et al. Cigarette smoke prevents apoptosis through inhibition of caspase activation and induces necrosis[J]. Am J Respir Cell Mol Biol，2003, 29(5):562-570.
0
浏览量
21
下载量
0
CSCD
- 网络PDF下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies